FI910925A0 - OXETANONER. - Google Patents

OXETANONER.

Info

Publication number
FI910925A0
FI910925A0 FI910925A FI910925A FI910925A0 FI 910925 A0 FI910925 A0 FI 910925A0 FI 910925 A FI910925 A FI 910925A FI 910925 A FI910925 A FI 910925A FI 910925 A0 FI910925 A0 FI 910925A0
Authority
FI
Finland
Prior art keywords
oxetanoner
oxetanones
novel
formula
image
Prior art date
Application number
FI910925A
Other languages
Finnish (fi)
Other versions
FI910925A (en
FI115054B (en
Inventor
Romano Derungs
Hans Peter Maerki
Henri Stalder
Andre Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI910925A0 publication Critical patent/FI910925A0/en
Publication of FI910925A publication Critical patent/FI910925A/en
Application granted granted Critical
Publication of FI115054B publication Critical patent/FI115054B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

Novel oxetanones inhibiting pancreatic lipase, of the formula <IMAGE> in which Q, R<1> and R<2> have the meaning given in the description, are disclosed, which are prepared starting from the corresponding beta -hydroxycarboxylic acids.
FI910925A 1990-02-26 1991-02-26 A process for the preparation of therapeutically useful oxetanones FI115054B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH60490 1990-02-26
CH60490 1990-02-26
CH400590 1990-12-17
CH400590 1990-12-17

Publications (3)

Publication Number Publication Date
FI910925A0 true FI910925A0 (en) 1991-02-26
FI910925A FI910925A (en) 1991-08-27
FI115054B FI115054B (en) 2005-02-28

Family

ID=25685091

Family Applications (1)

Application Number Title Priority Date Filing Date
FI910925A FI115054B (en) 1990-02-26 1991-02-26 A process for the preparation of therapeutically useful oxetanones

Country Status (18)

Country Link
EP (1) EP0444482B1 (en)
JP (1) JP2753403B2 (en)
KR (1) KR0183036B1 (en)
AT (1) ATE133167T1 (en)
AU (1) AU645291B2 (en)
CA (1) CA2035967C (en)
DE (1) DE59107262D1 (en)
DK (1) DK0444482T3 (en)
ES (1) ES2082869T3 (en)
FI (1) FI115054B (en)
GR (1) GR3019618T3 (en)
HU (1) HU218272B (en)
IE (1) IE72196B1 (en)
IL (1) IL97148A (en)
MC (1) MC2226A1 (en)
NO (1) NO177055C (en)
NZ (1) NZ237170A (en)
PT (1) PT96887B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
NL1004559C2 (en) * 1996-11-18 1998-05-19 Unilife Butter.
WO2001032616A2 (en) * 1999-10-29 2001-05-10 John Jason Gentry Mullins Oxetanone derivatives
US6348492B1 (en) * 1999-10-29 2002-02-19 2Pro Chemical Oxetanone derivatives
US6342519B2 (en) * 1999-10-29 2002-01-29 2 Pro Chemical Oxetanone derivatives
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
DE102004009076A1 (en) * 2004-02-23 2005-10-27 Solvay Pharmaceuticals Gmbh Alkylcarbamate-substituted β-lactones, processes and intermediates for their preparation, and medicaments containing these compounds
CA2704462A1 (en) 2007-10-31 2009-05-07 Burnham Institute For Medical Research Beta-lactone compounds
CN111343999B (en) * 2017-07-12 2022-03-01 梅约医学教育与研究基金会 Compounds for reducing lipotoxic damage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (en) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 New physiologically active substance esterastin and its production method
GB2023604B (en) * 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
JPH0669130B2 (en) * 1984-08-09 1994-08-31 三菱電機株式会社 Delay line

Also Published As

Publication number Publication date
HU218272B (en) 2000-07-28
MC2226A1 (en) 1993-02-02
AU7122891A (en) 1991-08-29
IE72196B1 (en) 1997-03-26
ES2082869T3 (en) 1996-04-01
FI910925A (en) 1991-08-27
AU645291B2 (en) 1994-01-13
JPH0770099A (en) 1995-03-14
DK0444482T3 (en) 1996-05-06
KR0183036B1 (en) 1999-05-01
EP0444482A3 (en) 1991-12-04
PT96887B (en) 1998-09-30
DE59107262D1 (en) 1996-02-29
CA2035967C (en) 2001-10-16
ATE133167T1 (en) 1996-02-15
JP2753403B2 (en) 1998-05-20
NO177055C (en) 1995-07-12
NO910729L (en) 1991-08-27
FI115054B (en) 2005-02-28
IL97148A (en) 1996-11-14
EP0444482B1 (en) 1996-01-17
EP0444482A2 (en) 1991-09-04
NO910729D0 (en) 1991-02-25
HUT56557A (en) 1991-09-30
IE910631A1 (en) 1991-08-28
GR3019618T3 (en) 1996-07-31
IL97148A0 (en) 1992-05-25
KR910021391A (en) 1991-12-20
NZ237170A (en) 1993-12-23
NO177055B (en) 1995-04-03
CA2035967A1 (en) 1991-08-27
PT96887A (en) 1991-10-31

Similar Documents

Publication Publication Date Title
ES2152414T3 (en) DIHYDROBENZOFURANS.
DE69521615D1 (en) PURIFIED STREPTOGRAMINE, THEIR PRODUCTION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK0444482T3 (en) oxetanones
ATE144498T1 (en) PREPARATION OF SUBSTITUTED PIPERIDINES
DE69106925T2 (en) Curable fluorescent siloxane compositions.
DK0696278T3 (en) Herbicide-acting substituted 1-phenyl- or 1-pyridinylbenzotriazoles
DK0623620T3 (en) 5-HT 3 pyrrolopyrazinderivater
FI915801A (en) COMPOSITION OF FOERFARANDE FOER ATT FOERHINDRA FLUOROS.
PT87563A (en) PROCESS FOR THE PREPARATION OF VINYLCEPHALOSPORINS USEFUL AS MEDICAMENTS
ATE140228T1 (en) HYDROXYMETHYL-INDOLIZIDINES AND -QUINOLICIDINES
DK0614908T3 (en) Process for the preparation of 3beta-aminocholanoic acid derivatives.
DK0552631T3 (en) Alpha-aryl-alpha-hydroxy-beta-imidazolinyl propionsyreamider
EP0529444A3 (en) 2-arylpropenic acids and their utilisation in the preparation of 5-ketoprofen
IL107142A0 (en) Tetrahydroindazolone pharmaceutical compositions
DE69100847T2 (en) Process for the preparation of 4,4&#39;-dihydroxybiphenyl.
FR2691353B1 (en) IMPLANT HOLDING AN INTRAOCULAR LENS.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115054

Country of ref document: FI

MA Patent expired